Vaxart Dividends and Buybacks
Dividend criteria checks 0/6
Vaxart does not have a record of paying a dividend.
Key information
n/a
Dividend yield
-41.6%
Buyback Yield
Total Shareholder Yield | -41.6% |
Future Dividend Yield | n/a |
Dividend Growth | n/a |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | n/a |
Payout ratio | n/a |
Recent dividend and buyback updates
No updates
Recent updates
Investors Give Vaxart, Inc. (NASDAQ:VXRT) Shares A 29% Hiding
Nov 16There's Reason For Concern Over Vaxart, Inc.'s (NASDAQ:VXRT) Massive 39% Price Jump
Aug 20An Intrinsic Calculation For Vaxart, Inc. (NASDAQ:VXRT) Suggests It's 26% Undervalued
Jun 15Here's Why Vaxart (NASDAQ:VXRT) Must Use Its Cash Wisely
Nov 08Vaxart (NASDAQ:VXRT) Will Have To Spend Its Cash Wisely
Jun 30Vaxart: The Market Still Isn't Buying Oral Vaccine Thesis
Sep 09Ray Stapleton joins Vaxart as CTO
Aug 31Vaxart shareholders approve proposal to increase number of shares
Aug 05Vaxart continues to lobby shareholders to vote to increase number of shares
Jul 29Vaxart oral COVID-19 pill vaccine candidate induces long-lasting antibodies against SARS-CoV-2
Jul 20Vaxart says recent CRO agreement 'may be integral' to oral COVID vaccine success
Jul 07Vaxart: A Unique Vaccine Concern
Jun 14Vaxart: A Speculative Biotech With Potential As Covid-19 Play And Oral Vaccine Platform
Feb 26Vaxart: Investment Case For An Oral COVID Vaccine Not So Hard To Swallow
Dec 09Vaxart: Differentiated Covid Oral Route Remains Viable
Nov 16Vaxart: A Close Look At Their COVID-19 Oral Tablet Vaccine Program
Oct 30Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if VXRT's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if VXRT's dividend payments have been increasing.
Dividend Yield vs Market
Vaxart Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (VXRT) | n/a |
Market Bottom 25% (US) | 1.4% |
Market Top 25% (US) | 4.2% |
Industry Average (Biotechs) | 2.3% |
Analyst forecast (VXRT) (up to 3 years) | n/a |
Notable Dividend: Unable to evaluate VXRT's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate VXRT's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate VXRT's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as VXRT has not reported any payouts.